Screener
Perrigo Company PRGO Infant Formula — Net Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Perrigo Company in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Perrigo Company’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 1:44 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001585364-26-000145
| Line item | Three Months Ended / June 27, 2026 | Three Months Ended / June 28, 2025 | Six Months Ended / June 27, 2026 | Six Months Ended / June 28, 2025 |
|---|---|---|---|---|
| Total Self Care | $576.6 | $598.6 | $1,119.9 | $1,212.8 |
| Specialty Care | ||||
| Skin Health | $161.8 | $170.3 | $313.7 | $319.9 |
| Women's Health | 64.8 | 62.7 | 119.9 | 112.3 |
| Total Specialty Care | $226.6 | $233.1 | $433.6 | $432.2 |
| Infant Formula | $100.9 | $82.0 | $190.6 | $169.8 |
| All Other(1) | $118.6 | $142.7 | $247.8 | $285.4 |
| Total net sales | $1,022.8 | $1,056.3 | $1,992.0 | $2,100.2 |
ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)
FAQ
- What is Perrigo Company's infant formula — net sales?
- Perrigo Company (PRGO) reported infant formula — net sales of $100.9M in Q2 2026.
- What does infant formula — net sales mean?
- This metric represents the total revenue generated from the sale of infant formula products within the specified business segment. It reflects the market demand and pricing power of the company's infant nutrition portfolio. Tracking this figure helps investors assess the segment's top-line growth and competitive positioning in the consumer health market.
Ask your AI about Perrigo Company's infant formula — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude